On one piece of health reform, at least, the politicians seem to have hit a good compromise: generic biologic drugs. As my book "Inside the FDA" explains, it's tough to concoct safe copies of biologic drugs like vaccines, which are made from actual natural materials like cells, rather than by manipulating chemical structures to make, say, Lipitor. Yet a patient could save thousands of dollars:a year on generic copies, as we do with Lipitor's generic rival, simvastatin. So Congress has figured out a compromise where generic biologic drugs would more extra FDA testing than chemicals. Sounds good..